Tuberculosis in special populations

被引:9
|
作者
Santin Cerezales, Miguel [1 ]
Navas Elorza, Enrique [2 ]
机构
[1] Univ Barcelona, Inst Salud Carlos III, IDIBELL,Dept Ciencias Clin, Hosp Univ Bellvitge,Serv Enfermedades Infecciosas, Barcelona, Spain
[2] Hosp Univ Ramon y Cajal, Serv Enfermedades Infecciosas, Madrid, Spain
关键词
Tuberculosis; Immunosupression; Comorbidity; Immigration; RECONSTITUTION INFLAMMATORY SYNDROME; HIV-INFECTED PERSONS; FOREIGN-BORN PERSONS; PULMONARY TUBERCULOSIS; MYCOBACTERIUM-TUBERCULOSIS; ANTITUBERCULOSIS DRUGS; ANTIRETROVIRAL THERAPY; COST-EFFECTIVENESS; RISK-FACTORS; TRANSMISSION;
D O I
10.1016/S0213-005X(11)70014-3
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
The susceptibility to infection, the pathogenesis and the clinical manifestations of tuberculosis (TB) depend on the immunological status of the host. Immunological status is largely determined by age and comorbidities, but is also affected by other less well known factors. In Spain, most incidental cases of TB arise from the reactivation of remotely acquired latent infections and are favored by the aging of the population and the use of aggressive immunosuppressive therapies. The diagnosis and management of TB in these circumstances is often challenging. On the one hand, the atypical presentation with extrapulmonary involvement may delay diagnosis, and on the other, the toxicity and interactions of the antituberculous drugs frequently make treatment difficult. Immigration from resource-poor, high incidence TB countries, where the social and economic conditions are often suboptimal, adds a new challenge to the control of the disease in Spain. This chapter summarizes our current knowledge of epidemiological, clinical and treatment aspects of TB in particularly susceptible populations. (C) 2011 Elsevier Espana, S.L. All rights reserved.
引用
收藏
页码:20 / 25
页数:6
相关论文
共 50 条
  • [1] Chapter 10: Treatment of active tuberculosis in special populations
    Cooper, Ryan
    Houston, Stan
    Hughes, Christine
    Johnston, James C.
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2023, 7 (06) : 436 - 455
  • [2] Chapter 10: Treatment of active tuberculosis in special populations
    Cooper, Ryan
    Houston, Stan
    Hughes, Christine
    Johnston, James C.
    CANADIAN JOURNAL OF RESPIRATORY CRITICAL CARE AND SLEEP MEDICINE, 2022, 6 : 149 - 166
  • [3] Special Populations and Pharmacogenetic Issues in Tuberculosis Drug Development and Clinical Research
    McIlleron, Helen
    Abdel-Rahman, Susan
    Dave, Joel Alex
    Blockman, Marc
    Owen, Andrew
    JOURNAL OF INFECTIOUS DISEASES, 2015, 211 : S115 - S125
  • [4] Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations
    Roland Diel
    Niklas Lampenius
    Albert Nienhaus
    PharmacoEconomics, 2015, 33 : 783 - 809
  • [5] Cost Effectiveness of Preventive Treatment for Tuberculosis in Special High-Risk Populations
    Diel, Roland
    Lampenius, Niklas
    Nienhaus, Albert
    PHARMACOECONOMICS, 2015, 33 (08) : 783 - 809
  • [6] Why a special issue of JIDC on tuberculosis and HIV among key populations in Ukraine?
    Klepikov, Andriy
    Basenko, Anton
    Lyashko, Viktor
    JOURNAL OF INFECTION IN DEVELOPING COUNTRIES, 2019, 13 (07): : 81S - 82S
  • [7] New anti-tuberculosis drugs for special populations: a difficult-to-address issue
    Sotgiu, Giovanni
    Pontali, Emanuele
    Centis, Rosella
    D'Ambrosio, Lia
    Migliori, Giovanni Battista
    EUROPEAN RESPIRATORY JOURNAL, 2016, 48 (03) : 957 - 958
  • [8] Special Populations
    不详
    FUTURE OF CHILDREN, 2003, 13 (01): : 98 - 99
  • [9] Special populations
    Zohar, Joseph
    Fostick, Leah
    Black, Donald W.
    Lopez-lbor, Juan J.
    CNS SPECTRUMS, 2007, 12 (02) : 36 - 42